中文 | English
Return
Total: 82 , 1/9
Show Home Prev Next End page: GO
Author:(Lanfang LI)

1.Relationship between Sfrp5 and T2DM macroangiopathy and activation of calcium dobesilate

Lanfang LI ; Jiaoe ZENG

The Journal of Practical Medicine 2016;32(18):3044-3046

2.The study progress and second-line chemotherapy of small cell lung cancer

Lanfang LI ; Huaqing WANG

Cancer Research and Clinic 2000;0(06):-

3.Effects of L-arginine on lipopolysaccharides-induced acute lung injury by inhibiting apoptotic pathway

Liping LI ; Jianxin ZHANG ; Lanfang LI

Chinese Journal of Pharmacology and Toxicology 2009;23(6):417-422

4.Effect of aminoguanidine on inflammatory reaction and nuclear Factor-?B signal pathway in the lipopolysaccharide-induced acute lung injury in rats

Liping LI ; Jianxin ZHANG ; Lanfang LI

Chinese Pharmacological Bulletin 2003;0(11):-

5.Effect of aminoguanidine on pulmonary surfactant and alveolar macrophages in the rats induced by LPS

Liping LI ; Jianxin ZHANG ; Lanfang LI

Chinese Pharmacological Bulletin 2003;0(07):-

6.Study on quality standard for Compound Xiaojingtong Capsules

Cunman LI ; Lanfang LI ; Qinzeng ZHANG

Chinese Traditional Patent Medicine 1992;0(08):-

7.Effects of L-arginine on LPS-induced lung mitochondrial injury in rats

Jianxin ZHANG ; Lanfang LI ; Tao SHANG

Chinese Journal of Anesthesiology 2009;29(3):250-253

8.Preliminary identification of children with acute lymphoblastic leukemia and juvenile idiopathic arthritis

Chen LI ; Lanfang CAO ; Haiyan XUE

International Journal of Pediatrics 2014;(5):542-543,567

9.Effects of L-arginine on the focal cerebral ischemic injury in rats

Jianxin ZHANG ; Huixin ZHANG ; Lanfang LI

Chinese Journal of Anesthesiology 1994;0(03):-

10.Propofol protects hearts from ischemia/reperfusion injury through interfering with the mitochondria-dependent apoptotic pathway

Lijun XIE ; Jianxin ZHANG ; Lanfang LI

Chinese Pharmacological Bulletin 1986;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 82 , 1/9 Show Home Prev Next End page: GO